Mutant calreticulin proteins are aberrantly exposed on the MPN cell surface while being bound to the thrombopoietin receptor MPL, causing the constitutive stimulation of the JAK-STAT pathway in MPN cells but not in CALR wildtype hematopoietic cells. The gene discussed is MPL; the disease is myeloproliferative neoplasm.